Fermenta Biotech Limited (FERMENTA) — Announcement | 10 August 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Company schedules one-to-one investor meetings
💡 Investor Takeaway
Shareholders should monitor the upcoming meetings for potential updates on business strategy.

Fermenta Biotech Limited announced it will hold one-to-one investor meetings on August 17, 2026, in Mumbai, to discuss press releases and investor presentations available on its website and BSE’s site, with no unpublished price-sensitive information to be shared.

📄 View Original Announcement (PDF)

About Fermenta Biotech Limited (FERMENTA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹1,471.99 Cr P/E: 24.3 ROE: 14.3% ROCE: 18.1% Div Yield: 0.75%

View full FERMENTA stock details →

📡 Get AI alerts when FERMENTA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track FERMENTA — Free

📊 More FERMENTA filings

See all FERMENTA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when FERMENTA files new disclosures

Track FERMENTA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track FERMENTA — Free

Free account · 2 AI queries/day